Adaptive Biotechnologies (ADPT) Asset Utilization Ratio (2019 - 2026)

Adaptive Biotechnologies has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.58 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.58, up 60.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.58 (up 60.69% YoY), and the FY2025 annual result was 0.53, up 76.6% from the prior year.
• Asset Utilization Ratio came in at 0.58 for Q1 2026 at Adaptive Biotechnologies, up from 0.55 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.58 in Q1 2026 to a low of 0.17 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.22 (2023), against an average of 0.3.
• Across the five-year window, Asset Utilization Ratio fell 12.07% in 2023 and surged 74.16% in 2024, its largest moves.
• Adaptive Biotechnologies' Asset Utilization Ratio stood at 0.21 in 2022, then dropped by 12.07% to 0.19 in 2023, then soared by 74.16% to 0.33 in 2024, then soared by 69.36% to 0.55 in 2025, then advanced by 5.05% to 0.58 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.58 (Q1 2026), 0.55 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.